lobbying_activities: 745822

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
745822	13d3722c-5118-4f5a-817f-e71530b96e50	Q1	DUTKO WORLDWIDE, LLC	12868	BIOGENIDEC	2009	first_quarter	CPT	Monitoring implementation and legislation affecting the IP issues in health care: legislation to create a regulatory pathway for biosimiliars, Pathway for Biosimilars Act (H.R. 1548) and Health Care Reform Legislation (to date no specific bills have been introduced).	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2009-04-08T13:40:56-04:00